Trial design of CAR T cell therapy for autoimmune diseases
Technological advancements, including in vivo delivery, RNA payloads, combination treatments, multi-specifics and T cell engagers, as well as gene editing, are expanding CAR T applications from cancer to autoimmune disease. These applications present distinct opportunities for randomized controlled trials of CAR T cell therapies.